
Sattva Sukun Lifecare Faces Mixed Financial Performance Amid Market Evaluation Adjustment
2025-04-02 08:38:49Sattva Sukun Lifecare has recently adjusted its evaluation, reflecting changes in financial metrics and market position. The company's performance shows mixed results, with a notable rise in profits but underperformance against market benchmarks. Technical indicators suggest a cautious outlook amid a period of stability in its trend.
Read MoreSattva Sukun Lifecare Adjusts Valuation Amidst Competitive Trading Sector Dynamics
2025-04-01 08:00:37Sattva Sukun Lifecare, a microcap player in the trading industry, has recently undergone a valuation adjustment, reflecting a shift in its financial standing. The company's current price stands at 1.10, slightly above its previous close of 1.05, with a 52-week high of 1.65 and a low of 0.74. Key financial metrics reveal a PE ratio of 9.92 and an EV to EBITDA of 6.83, indicating a competitive position within its sector. The company's return on capital employed (ROCE) is reported at 9.83%, while the return on equity (ROE) is at 7.86%. These figures suggest a stable operational performance, although the stock has faced challenges, with a year-to-date return of -12.6%, contrasting with a slight decline in the Sensex of -0.93%. In comparison to its peers, Sattva Sukun's valuation metrics show it positioned differently against companies like Sat Industries and Kamdhenu, which exhibit varying degrees of attract...
Read MoreSattva Sukun Lifecare Adjusts Valuation Amidst Competitive Market Landscape
2025-03-11 08:00:37Sattva Sukun Lifecare, a microcap player in the trading industry, has recently undergone a valuation adjustment, reflecting a shift in its financial standing. The company's current price stands at 1.10, slightly above its previous close of 1.08, with a 52-week high of 2.10 and a low of 0.74. Key financial metrics reveal a PE ratio of 9.92 and an EV to EBITDA ratio of 6.83, indicating a specific positioning within the market. The company's return on capital employed (ROCE) is reported at 9.83%, while the return on equity (ROE) is at 7.86%. These figures provide insight into Sattva Sukun's operational efficiency and profitability. When compared to its peers, Sattva Sukun's valuation metrics stand out, particularly in the context of its price-to-earnings ratio and EV to EBITDA, which are significantly lower than those of some competitors. For instance, Uniphos Enterprises shows a notably high PE ratio, whil...
Read MoreSattva Sukun Lifecare Adjusts Valuation Amidst Competitive Trading Sector Landscape
2025-02-25 10:23:38Sattva Sukun Lifecare, a microcap player in the trading industry, has recently undergone a valuation adjustment. The company's financial metrics reveal a price-to-earnings (PE) ratio of 9.74 and an enterprise value to EBITDA ratio of 6.70. Additionally, the price-to-book value stands at 0.90, while the return on capital employed (ROCE) is reported at 9.83%. In comparison to its peers, Sattva Sukun's valuation metrics indicate a competitive position within the market. For instance, Fratelli Vineyard is noted as loss-making, while Kamdhenu shows a higher PE ratio of 14.34. Zuari Industries stands out with a more attractive valuation, featuring a PE ratio of 22.99. Other peers like STEL Holdings and Shiv Texchem exhibit significantly higher valuation metrics, suggesting a varied landscape in the trading sector. Sattva Sukun's stock performance has faced challenges, with a notable decline over the past month...
Read More
Sattva Sukun Lifecare Reports Strong Q3 FY24-25 Results with Record Operating Profit
2025-02-11 21:37:28Sattva Sukun Lifecare has announced its financial results for Q3 FY24-25, highlighting significant achievements. The company reported its highest operating profit, profit before tax, and profit after tax in the last five quarters. Additionally, it improved its debtor turnover ratio, indicating enhanced efficiency in managing receivables.
Read More
Sattva Sukun Lifecare Reports Strong Q2 Growth Amid Long-Term Financial Concerns
2025-01-27 19:19:18Sattva Sukun Lifecare has recently experienced a change in evaluation, reflecting its financial performance for Q2 FY24-25. The company reported a strong growth trajectory in net sales, but concerns remain about its long-term financial stability and debt servicing capabilities, despite achieving a notable return on capital employed.
Read MoreDisclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
07-Apr-2025 | Source : BSEThis is with reference to the in-principle approval granted by the BSE for the proposed right issue of sattva sukun lifecare limited (the company) wherein the company seeks to raise Rs. 49.50 Crore to meet working capital requirements support business expansion and invest in existing subsidiaries
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Read With SEBI Circular SEBI/HO/CFD/CFD-Pod1/P/CIR/2023/123 Dated July 13 2023.
03-Apr-2025 | Source : BSEIn Compliance with regulation 30 (4) of the SEBI (Listing Obligations and disclosure requirement) Regulation 2015 we are pleased to inform you that the company has received a purchase order from Mangalam Brands pvt ltd. for 10000 units of the Electric kapoor dani (Wooden) Sheesham wood with carving design temperature heating timing 240 degree in 5 minutes & will stable at 240 degree LED Colour-Red.
Intimation Of In-Principle Approval Received For Rights Issue Of Fully Paid-Up Equity Shares By Sattva Sukun Lifecare Limited (The Company) Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirements)
27-Mar-2025 | Source : BSEBSE In-Principle Approval for Right Issue.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
Sattva Sukun Lifecare Ltd has announced 1:5 stock split, ex-date: 25 Oct 24
Sattva Sukun Lifecare Ltd has announced 3:5 bonus issue, ex-date: 17 Jan 25
No Rights history available